In the most recent period of Q1'26, CVS's ROE stands at 3.80%, ROA at 1.16%, and ROIC at 2.04%, reflecting a solid recovery in profitability metrics following the previous quarter's downturn. These figures indicate improved operational efficiency and return generation on assets and equity, with all indicators showing positive values after a challenging Q3'25. Over the period from Q2'23 to Q1'26, the chart reveals volatile trends in CVS's operating profitability metrics, with ROE, ROA, and ROIC generally fluctuating between 0.3% and 3.9%, marked by a sharp decline to negative territory in Q3'25 (ROE at -5.45%, ROA at -1.56%, ROIC at -2.06%) before rebounding strongly in Q4'25 and stabilizing in Q1'26. Key inflection points include a low in Q3'24 for ROA (0.03%) and ROIC (0.53%), contrasted by peaks in Q3'23 (ROE 3.04%, ROA 0.90%, ROIC 1.91%), highlighting periodic pressures on asset utilization amid overall modest growth in returns. The line chart underscores a resilient but inconsistent pattern, with ROE consistently outperforming ROA and ROIC, suggesting effective leverage in equity returns despite asset-level challenges.